Home > Products

Product Description

SALAGEN®

Salagen® (Pilocarpine hydrochloride, oral tablet, 5mg) is used to manage symptoms of xerostomia (dry mouth) associated with radiation therapy (head and neck) as well as to manage symptoms of xerostomia (dry mouth) and xerophthalmia (dry eyes) in patients with Sj√∂gren's syndrome.

Marketed in Austria, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Italy, Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden, Switzerland.

Licensing opportunities available in Albania, Armenia, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Georgia, Ireland, Kazakhstan, Kyrgyzstan, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Romania, Russia, Serbia, Slovakia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.

® Registered trademark of Eisai Inc. used under License.

ESTRADERM®

Estraderm® is a patch medication containing estrogen (a female hormone). It is used to treat woman to help reduce symptoms of menopause, such as hot flashes, vaginal dryness.

Marketed in Australia, Italy, Poland, Spain, and UK.

Licensing opportunities available in Austria, Belgium, Bulgaria, Colombia, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Portugal, Republic of Cyprus, Romania, Slovakia, Slovenia, Sweden, and Switzerland.

® Registered trademark of Novartis used under License.

SURGESTONE®

Surgestone® (promegestrone) is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea, and premenstrual syndrome.

Marketed in France.

Licensing opportunities available in A.I.P.O (see below), Bolivia, China, Kosovo, Monaco, Morocco, Portugal, and S. Korea.

A.I.P.O includes Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Comoro Islands, Congo, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Ivory Coast, Ma, Mauritania, Niger, Senegal, and Togo.

PROVAMES®

Provames® (estradiol) is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Marketed in France.

SPECIAFOLDINE®

Speciafoldine® (folic acid) is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.

Marketed in France.

SINTROM®

Sintrom® (acenocoumarol) is an anticoagulant indicated to treat and prevent thromboembolic diseases.

Marketed in Albania, Austria, Belgium, Bosnia-Herzegowina, Bulgaria, France (including French overseas territories), Greece, Ireland, Italy, Kosovo, Macedonia, Montenegro, Poland, Portugal, Romania, Slovenia, Spain (including Andorra), and UK.

Licensing opportunities available in Luxembourg.

® Registered trademark of Novartis used under License.

ELANTAN®

Elantan® (isosorbide mononitrate) are tablets or capsules that belong to a group of medicines called organic nitrates.

Marketed in Austria, Belgium, Bulgaria, Czech Republic, Finland, Germany, Hungary, Ireland, Italy, S. Korea, Latvia, Luxembourg, Mexico, Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and UK.

Licensing opportunities available in Bosnia & Herzegovina, Croatia, Cyprus, Denmark, Estonia, France, Greece, Iceland, India, Lithuania, Macedonia, Malta, Serbia, and Slovenia.

ISOKET®

Isoket® (isosorbide dinitrate) belongs to a group of medicines called organic nitrates.

Marketed in Austria, Belgium, Bulgaria, Czech Republic, Finland, Germany, Hungary, Ireland, Italy, S. Korea, Latvia, Luxembourg, Mexico, Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and UK.

Licensing opportunities available in Australia, Bosnia & Herzegovina, Croatia, Cyprus, Estonia, France, Greece, India, Liechtenstein, Lithuania, Macedonia, Malta, Monaco, Romania, San-Marino, Serbia, and Slovenia.

DEPONIT®

Deponit® (glyceryl trinitrate) belongs to a group of medicines called nitrates.

Marketed in Austria, Belgium, Bulgaria, Czech Republic, Finland, Germany, Hungary, Ireland, Italy, Korea, Latvia, Luxembourg, Mexico, Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and UK.

Licensing opportunities available in Australia, Bolivia, Bosnia & Herzegovina, Brazil, Croatia, Cyprus, Denmark, Estonia, France, Greece, India, Liechtenstein, Lithuania, Macedonia, Malta, Monaco, North Korea, Romania, San-Marino, Serbia, and Slovenia.

EMSELEX® / ENABLEX®

Emselex® (darifenacin), or Enablex®, is used in adults to treat overactive bladder syndrome.

Marketed in Belgium, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Finland, Germany, Gibraltar, Great Britain, Greece, Hungary, Iceland, Ireland, Jersey, Luxemburg, Malta, Netherlands, Norway, Portugal, Serbia, Slovakia, Slovenia, Sweden, and Switzerland.

Licensing opportunities available in Austria, Albania, Estonia, Latvia, Lithuania, Poland, and Romania.

VANCOCIN®

Vancocin® (vancomycin) capsules are indicated to treat infections caused by bacteria such as C. difficile in the gastrointestinal tract.

Marketed in Canada.

TREDEMINE®

Tredemine® is used in the treatment of taeniasis, a parasitic disease caused by tapeworm infection.

Marketed in France.